9:00 AM SIGN-IN • 9:30 AM - 11:00 AM
BANDOL 2 (NEW WYNN SPACE)
CE: The Dynamic Landscape of CLL and Its Effect on Specialty Pharmacy Practice
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, with more than 20,000 patients diagnosed annually in the United States. New and expanded approvals in the past 12 months are changing the treatment landscape and ultimately the outcomes of patients with CLL. Evidence for the use of oral monotherapy, oral combination therapies, and oral oncolytics in combination with chemoimmunotherapy is rapidly progressing. Specialty pharmacists are uniquely positioned to manage and counsel patients as well as to advise health care professionals about adverse effects and novel guideline-recommended targeted options. This session will highlight the latest information on therapeutic strategies for patients with CLL as well as the pharmacist’s role in developing patient-centered solutions, including coordination of care across practice settings, adherence and monitoring strategies, and patient self-care management.